IL6 and breast carcinoma: Furthermore, the combination of both serum TPA and IL-6 levels have found to increase the specificity in detecting breast cancer up to (96.7%) and up to authors knowledge this is the first study estimated the specificity and sensitivity of the combination of these tumor markers in the diagnosis and follow up of patients with breast cancer on chemotherapy.